Navigating the challenges of mass vaccine production

Watson-Marlow Fluid Technology Group (WMFTG) launches a new article discussing the challenges of rapidly scaling up vaccine production to meet global demands.
Navigating the challenges of mass vaccine production

New report of the Watson-Marlow Fluid Technology Group published. (Image source: Watson-Marlow Fluid Technology Group)

The opinion piece looks at the significant progress being made in the development of novel vaccine candidates for SARS-CoV-2, shortening development timelines from years to months. Exploring the challenges that remain to scale up production to billions of doses worldwide, experts present their view on the innovation and collaboration needed from the bioprocessing industry to reach this target and the WMFTG technologies currently being used in the process.

In light of the COVID-19 pandemic and the need for a vaccine, biopharmaceutical processing experts have had to adapt technologies to accelerate the vaccine development process and step up manufacturing rapidly from small scale research to clinical trials, and on to widespread production. Knowledge transfer from adjacent fields, such as gene therapy, is vital in order to overcome this new challenge. The use of validated, single-use technologies will be essential to scale efficiently whilst maintaining product quality and satisfying regulatory requirements.

The new article is authored by bioprocessing experts from WMFTG; Jim Sanford, Dr Sade Mokuolu and Peter Birch, with insights from Cobra Biologics’ Technical Director, Tony Hitchcock.

“The technology must be the same in every manufacturing site, that’s how we will achieve process validation and meet the regulatory standards,” commented Tony. “Hopefully, these collaborations will create something truly ground-breaking, based on the very real and solid foundation of tried and test technology.”

More articles on this topic

Drive Suppliers Facing Supply Problems Across the Board

08.07.2021 -

Drives market revenues fell by 5-10 percent in 2020 as a result of the COVID-19 pandemic. While the first half of 2020 saw steep declines in sales, many suppliers were able to offset those losses with a strong performance in the second half of the year. Now, as economies reopen, the aftereffects of COVID-19 are becoming glaringly apparent.

Read more

Pentair Announces Social Responsibility Strategic Targets

11.06.2021 -

Pentair plc announced its Social Responsibility Strategic Targets. The new targets were launched with the release of Pentair’s 2020 Corporate Responsibility Report, which highlights the company’s initiatives to be a leading socially responsible company as it delivers smart, sustainable solutions that empower customers and employees to make the most of life’s essential resources.

Read more
Directly to the product selection in



  • Advertisement